These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Muscarinic receptors as a target for drugs treating schizophrenia. Bymaster FP; Felder C; Ahmed S; McKinzie D Curr Drug Targets CNS Neurol Disord; 2002 Apr; 1(2):163-81. PubMed ID: 12769625 [TBL] [Abstract][Full Text] [Related]
6. Atypical antipsychotics: mechanism of action. Seeman P Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706 [TBL] [Abstract][Full Text] [Related]
7. N-(3-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}propyl)-1H-indazole-3-carboxamide (D2AAK3) as a potential antipsychotic: In vitro, in silico and in vivo evaluation of a multi-target ligand. Kaczor AA; Targowska-Duda KM; Stępnicki P; Silva AG; Koszła O; Kędzierska E; Grudzińska A; Kruk-Słomka M; Biała G; Castro M Neurochem Int; 2021 Jun; 146():105016. PubMed ID: 33722679 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous activation of muscarinic and GABA Cieślik P; Woźniak M; Tokarski K; Kusek M; Pilc A; Płoska A; Radulska A; Pelikant-Małecka I; Żołnowska B; Sławiński J; Kalinowski L; Wierońska JM Behav Brain Res; 2019 Feb; 359():671-685. PubMed ID: 30267715 [TBL] [Abstract][Full Text] [Related]
10. Multitarget 1,4-Dioxane Compounds Combining Favorable D Del Bello F; Ambrosini D; Bonifazi A; Newman AH; Keck TM; Giannella M; Giorgioni G; Piergentili A; Cappellacci L; Cilia A; Franchini S; Quaglia W ACS Chem Neurosci; 2019 May; 10(5):2222-2228. PubMed ID: 30609891 [TBL] [Abstract][Full Text] [Related]
11. The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance. Rasmussen T; Fink-Jensen A; Sauerberg P; Swedberg MD; Thomsen C; Sheardown MJ; Jeppesen L; Calligaro DO; DeLapp NW; Whitesitt C; Ward JS; Shannon HE; Bymaster FP Schizophr Res; 2001 Apr; 49(1-2):193-201. PubMed ID: 11343877 [TBL] [Abstract][Full Text] [Related]
12. Receptor mechanisms in the treatment of schizophrenia. Reynolds GP J Psychopharmacol; 2004 Sep; 18(3):340-5. PubMed ID: 15358977 [TBL] [Abstract][Full Text] [Related]
13. Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia. Kasper S; Tauscher J; Küfferle B; Barnas C; Pezawas L; Quiner S Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 4():83-9. PubMed ID: 10654113 [TBL] [Abstract][Full Text] [Related]
14. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Kapur S; Remington G Annu Rev Med; 2001; 52():503-17. PubMed ID: 11160792 [TBL] [Abstract][Full Text] [Related]
15. Geissoschizine methyl ether has third-generation antipsychotic-like actions at the dopamine and serotonin receptors. Ueda T; Ugawa S; Ishida Y; Shimada S Eur J Pharmacol; 2011 Dec; 671(1-3):79-86. PubMed ID: 21951966 [TBL] [Abstract][Full Text] [Related]
16. New (sulfonyloxy)piperazinyldibenzazepines as potential atypical antipsychotics: chemistry and pharmacological evaluation. Liao Y; Venhuis BJ; Rodenhuis N; Timmerman W; Wikström H; Meier E; Bartoszyk GD; Böttcher H; Seyfried CA; Sundell S J Med Chem; 1999 Jun; 42(12):2235-44. PubMed ID: 10377229 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and atypical antipsychotic profile of some 2-(2-piperidinoethyl)benzocycloalkanones as analogues of butyrophenone. Fontenla JA; Osuna J; Rosa E; Castro ME; G-Ferreiro T; Loza-García I; Calleja JM; Sanz F; Rodríguez J; Raviña E J Med Chem; 1994 Aug; 37(16):2564-73. PubMed ID: 7914540 [TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel N-sulfonyl-2-indoles that behave as 5-HT Saavedra OM; Karila D; Brossard D; Rojas A; Dupuis D; Gohier A; Mannoury la Cour C; Millan MJ; Ortuno JC; Hanessian S Bioorg Med Chem; 2017 Jan; 25(1):38-52. PubMed ID: 28029458 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological investigation of new equatorial (β) stereoisomers of 3-aminotropane arylamides with atypical antipsychotic profile. Stefanowicz J; Słowiński T; Wróbel MZ; Herold F; Gomółka AE; Wesołowska A; Jastrzębska-Więsek M; Partyka A; Andres-Mach M; Czuczwar SJ; Łuszczki JJ; Zagaja M; Siwek A; Nowak G; Żołnierek M; Bączek T; Ulenberg S; Belka M; Turło J Bioorg Med Chem; 2016 Sep; 24(18):3994-4007. PubMed ID: 27377863 [TBL] [Abstract][Full Text] [Related]
20. Arylpiperazinylalkyl derivatives of 8-amino-1,3-dimethylpurine-2,6-dione as novel multitarget 5-HT/D receptor agents with potential antipsychotic activity. Chłoń-Rzepa G; Bucki A; Kołaczkowski M; Partyka A; Jastrzębska-Więsek M; Satała G; Bojarski AJ; Kalinowska-Tłuścik J; Kazek G; Mordyl B; Głuch-Lutwin M; Wesołowska A J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1048-62. PubMed ID: 26406608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]